Genome-wide association studies (GWAS) have identified numerous genetic variants associated with Alzheimer's disease (AD), but their functional implications remain unclear. Transcriptome-wide association studies (TWAS) offer enhanced statistical power by analyzing genetic associations at the gene level rather than at the variant level, enabling assessment of how genetically-regulated gene expression influences AD risk. However, previous AD-TWAS have been limited by small expression quantitative trait loci (eQTL) reference datasets or reliance on AD-by-proxy phenotypes.
Objective
To perform the most powerful AD-TWAS to date using summary statistics from the largest available brain and blood cis-eQTL meta-analyses applied to the largest clinically-adjudicated AD GWAS.
Methods
We implemented the OTTERS TWAS pipeline to predict gene expression using the largest available cis-eQTL data from cortical brain tissue (MetaBrain; N = 2683) and blood (eQTLGen; N = 31,684), and then applied these models to AD-GWAS data (Cases = 21,982; Controls = 44,944).
Results
We identified and validated five novel gene associations in cortical brain tissue (PRKAG1, C3orf62, LYSMD4, ZNF439, SLC11A2) and six genes proximal to known AD-related GWAS loci (Blood: MYBPC3; Brain: MTCH2, CYB561, MADD, PSMA5, ANXA11). Further, using causal eQTL fine-mapping, we generated sparse models that retained the strength of the AD-TWAS association for MTCH2, MADD, ZNF439, CYB561, and MYBPC3.
Conclusions
Our comprehensive AD-TWAS discovered new gene associations and provided insights into the functional relevance of previously associated variants, which enables us to further understand the genetic architecture underlying AD risk.
KarlssonIKEscott-PriceVGatzM, et al.Measuring heritable contributions to Alzheimer’s disease: polygenic risk score analysis with twins. Brain Commun2022; 4: fcab308.
2.
GatzMReynoldsCAFratiglioniL, et al.Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry2006; 63: 168–174.
3.
RidgePGHoytKBBoehmeK, et al.Assessment of the genetic variance of late-onset Alzheimer’s disease. Neurobiol Aging2016; 41: 200.e13–200.e20.
4.
WightmanDPJansenIESavageJE, et al.A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat Genet2021; 53: 1276–1282.
5.
BellenguezCKüçükaliFJansenIE, et al.New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet2022; 54: 412–436.
6.
LiuJZErlichYPickrellJK. Case-control association mapping by proxy using family history of disease. Nat Genet2017; 49: 325–331.
7.
Escott-PriceVHardyJ. Genome-wide association studies for Alzheimer’s disease: bigger is not always better. Brain Commun2022; 4: fcac125.
8.
NelsonMRTipneyHPainterJL, et al.The support of human genetic evidence for approved drug indications. Nat Genet2015; 47: 856–860.
9.
GallagherMDChen-PlotkinAS. The post-GWAS era: from association to function. Am J Hum Genet2018; 102: 717–730.
10.
KingEADavisJWDegnerJF. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet2019; 15: e1008489.
11.
de KleinNTsaiEAVochtelooM, et al.Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat Genet2023; 55: 377–388.
12.
VõsaUClaringbouldAWestraH-J, et al.Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet2021; 53: 1300–1310.
13.
NicaACDermitzakisET. Expression quantitative trait loci: present and future. Philos Trans R Soc Lond B Biol Sci2013; 368: 20120362.
14.
WheelerHEShahKPBrennerJ, et al.Survey of the heritability and sparse architecture of gene expression traits across human tissues. PLoS Genet2016; 12: e1006423.
15.
GamazonERWheelerHEShahKP, et al.A gene-based association method for mapping traits using reference transcriptome data. Nat Genet2015; 47: 1091–1098.
16.
MeltonHJZhangZWuC. SUMMIT-FA: a new resource for improved transcriptome imputation using functional annotations. Hum Mol Genet2023; 33: 624–635.
17.
DaiQZhouGZhaoH, et al. OTTERS: a powerful TWAS framework leveraging summary-level reference data. Nat Commun2023; 14: 1271.
18.
ZhangZBaeYEBradleyJR, et al. SUMMIT: an integrative approach for better transcriptomic data imputation improves causal gene identification. Nat Commun2022; 13: 6336.
19.
MakTSHPorschRMChoiSW, et al.Polygenic scores via penalized regression on summary statistics. Genet Epidemiol2017; 41: 469–480.
20.
Lloyd-JonesLRZengJSidorenkoJ, et al. Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat Commun2019; 10: 5086.
21.
VilhjálmssonBJYangJFinucaneHK, et al.Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am J Hum Genet2015; 97: 576–592.
GeTChenC-YNiY, et al. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun2019; 10: 1776.
24.
ZhouGZhaoH. A fast and robust Bayesian nonparametric method for prediction of complex traits using summary statistics. PLoS Genet2021; 17: e1009697.
25.
International Schizophrenia Consortium, PurcellSMWrayNR, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature2009; 460: 748–752.
26.
LuninghamJMChenJTangS, et al.Bayesian genome-wide TWAS method to leverage both cis- and trans-eQTL information through summary statistics. Am J Hum Genet2020; 107: 714–726.
27.
LiuWLiMZhangW, et al.Leveraging functional annotation to identify genes associated with complex diseases. PLoS Comput Biol2020; 16: e1008315.
28.
TangSBuchmanASDe JagerPL, et al.Novel variance-component TWAS method for studying complex human diseases with applications to Alzheimer’s dementia. PLoS Genet2021; 17: e1009482.
29.
SunYZhuJZhouD, et al.A transcriptome-wide association study of Alzheimer’s disease using prediction models of relevant tissues identifies novel candidate susceptibility genes. Genome Med2021; 13: 141.
30.
HuYLiMLuQ, et al.A statistical framework for cross-tissue transcriptome-wide association analysis. Nat Genet2019; 51: 568–576.
31.
BaeYEWuLWuC. InTACT: an adaptive and powerful framework for joint-tissue transcriptome-wide association studies. Genet Epidemiol2021; 45: 848–859.
32.
WangYHLuoPPGengAY, et al.Identification of highly reliable risk genes for Alzheimer’s disease through joint-tissue integrative analysis. Front Aging Neurosci2023; 15: 1183119.
33.
ZhouDJiangYZhongX, et al.A unified framework for joint-tissue transcriptome-wide association and Mendelian randomization analysis. Nat Genet2020; 52: 1239–1246.
34.
ChenH-HPettyLEShaJ, et al.Genetically regulated expression in late-onset Alzheimer’s disease implicates risk genes within known and novel loci. Transl Psychiatry2021; 11: 618.
35.
GockleyJMontgomeryKSPoehlmanWL, et al.Multi-tissue neocortical transcriptome-wide association study implicates 8 genes across 6 genomic loci in Alzheimer’s disease. Genome Med2021; 13: 76.
36.
GTEx Consortium. The GTEx consortium atlas of genetic regulatory effects across human tissues. Science2020; 369: 1318–1330.
37.
KunkleBWGrenier-BoleyBSimsR, et al.Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates aβ, tau, immunity and lipid processing. Nat Genet2019; 51: 414–430.
38.
Byrska-BishopMEvaniUSZhaoX, et al.High-coverage whole-genome sequencing of the expanded 1000 genomes project cohort including 602 trios. Cell2022; 185: 3426–3440. e19.
39.
LiuYChenSLiZ, et al.ACAT: a fast and powerful p value combination method for rare-variant analysis in sequencing studies. Am J Hum Genet2019; 104: 410–421.
40.
GriswoldAJSivasankaranSKVan BoovenD, et al.Immune and inflammatory pathways implicated by whole blood transcriptomic analysis in a diverse ancestry Alzheimer’s disease cohort. J Alzheimers Dis2020; 76: 1047–1060.
41.
PetyukVAChangRRamirez-RestrepoM, et al.The human brainome: network analysis identifies HSPA2 as a novel Alzheimer's disease target. Brain2018; 141: 2721–2739.
42.
AbrahamGQiuYInouyeM. FlashPCA2: principal component analysis of biobank-scale genotype datasets. Bioinformatics2017; 33: 2776–2778.
43.
ZouYCarbonettoPWangG, et al.Fine-mapping from summary data with the ‘sum of single Effects’ model. PLoS Genet2022; 18: e1010299.
44.
WangGSarkarACarbonettoP, et al.A simple new approach to variable selection in regression, with application to genetic fine mapping. J R Stat Soc Series B Stat Methodol2020; 82: 1273–1300.
45.
KuksaPPLeungYYGangadharanP, et al.FILER: a framework for harmonizing and querying large-scale functional genomics knowledge. NAR Genom Bioinform2022; 4: lqab123.
46.
DrivasTGLucasARitchieMD. eQTpLot: a user-friendly R package for the visualization of colocalization between eQTL and GWAS signals. BioData Mining2021; 14: 32.
47.
LarocheFJFTulottaCLamersGEM, et al.The embryonic expression patterns of zebrafish genes encoding LysM-domains. Gene Expr Patterns2013; 13: 212–224.
48.
KangHJKawasawaYIChengF, et al.Spatiotemporal transcriptome of the human brain. Nature2011; 478: 483–489.
49.
JohanssonPABrattåsPLDouseCH, et al.A cis-acting structural variation at the ZNF558 locus controls a gene regulatory network in human brain development. Cell Stem Cell2022; 29: 52–69. e8.
50.
LorenziMAltmannAGutmanB, et al.Susceptibility of brain atrophy to TRIB3 in Alzheimer’s disease, evidence from functional prioritization in imaging genetics. Proc Natl Acad Sci U S A2018; 115: 3162–3167.
51.
PappalardoXGJansenGAmaradioM, et al.Inferring gene regulatory networks of ALS from blood transcriptome profiles. Heliyon2024; 10: e40696.
52.
SebollelaAFreitas-CorreaLOliveiraFF, et al.Amyloid-β oligomers induce differential gene expression in adult human brain slices. J Biol Chem2012; 287: 7436–7445.
53.
YangLJiangYShiL, et al.AMPK: potential therapeutic target for Alzheimer’s disease. Curr Protein Pept Sci2020; 21: 66–77.
54.
AzimiMGharakhanlouRNaghdiN, et al.Moderate treadmill exercise ameliorates amyloid-β-induced learning and memory impairment, possibly via increasing AMPK activity and up-regulation of the PGC-1α/FNDC5/BDNF pathway. Peptides2018; 102: 78–88.
55.
JamiesonSEWhiteJKHowsonJMM, et al.Candidate gene association study of solute carrier family 11a members 1 (SLC11A1) and 2 (SLC11A2) genes in Alzheimer’s disease. Neurosci Lett2005; 374: 124–128.
56.
SpiersJGCortina ChenH-JBarryTL, et al.Redox stress and metal dys-homeostasis appear as hallmarks of early prion disease pathogenesis in mice. Free Radic Biol Med2022; 192: 182–190.
57.
HuangK-LMarcoraEPimenovaAA, et al.A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer’s disease. Nat Neurosci2017; 20: 1052–1061.
58.
WangYDuanXZhouX, et al.ANXA11 Mutations are associated with amyotrophic lateral sclerosis–frontotemporal dementia. Front Neurol2022; 13: 886887.
59.
WuYZhangSXuQ, et al.Regulation of global gene expression and cell proliferation by APP. Sci Rep2016; 6: 22460.
60.
MirzaeiMPushpithaKDengL, et al.Upregulation of proteolytic pathways and altered protein biosynthesis underlie retinal pathology in a mouse model of Alzheimer’s disease. Mol Neurobiol2019; 56: 6017–6034.
61.
ChocronESMunkácsyEKimHS, et al.Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer’s-like pathology in mouse and fly APP overexpression models. Sci Adv2022; 8: eabk2252.
62.
GuoSYangJ. Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer’s disease dementia. Alzheimers Res Ther2024; 16: 120.
63.
ParrishRLBuchmanASTasakiS, et al.SR-TWAS: leveraging multiple reference panels to improve transcriptome-wide association study power by ensemble machine learning. Nat Commun2024; 15: 6646.
64.
HeYZhuPGaoS, et al.Identification of Alzheimer’s disease susceptibility genes by integrating eight human brain single-cell transcriptomes with genome-wide association studies. J Neurochem2025; 169: e16276.
65.
LiuXLiYIPritchardJK. Trans effects on gene expression can drive omnigenic inheritance. Cell2019; 177: 1022–1034. e6.
66.
HeRXueHPanW. Statistical power of transcriptome-wide association studies. Genet Epidemiol2022; 46: 572–588.
67.
KachuriLChatterjeeNHirboJ, et al.Principles and methods for transferring polygenic risk scores across global populations. Nat Rev Genet2024; 25: 8–25.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
